Collectively, our results show that SF-Cyld controls TAK1 kinase to prevent IKK2 and NF-κB hyperactivation but not Ripk1-mediated death, leading to deterioration of arthritic phenotype in TNF-dependent arthritis. Here, NFKB1 is linked to arthritic joint disease.